Patient Assistance Program Allows Company to Increase Drug Prices While Passing Costs onto Insurance Companies and Consumers WASHINGTON, DC — In a letter sent today to the CEO of pharmaceutical company Mylan, U.S. Senators Jack Reed and Sheldon Whitehouse, along with 18 of their Senate colleagues, expressed their serious concerns about the company’s significant price […]readmore